These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35654819)

  • 1. Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms.
    Ernst P; Schnöder TM; Huber N; Perner F; Jayavelu AK; Eifert T; Hsu CJ; Tubío-Santamaría N; Crodel CC; Ungelenk M; Hübner CA; Clement JH; Hochhaus A; Heidel FH
    Leukemia; 2022 Jul; 36(7):1843-1849. PubMed ID: 35654819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM3A histone demethylase functions as an essential factor for activation of JAK2-STAT3 signaling pathway.
    Kim H; Kim D; Choi SA; Kim CR; Oh SK; Pyo KE; Kim J; Lee SH; Yoon JB; Zhang Y; Baek SH
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11766-11771. PubMed ID: 30377265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
    Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
    Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth.
    Gregory BL; Cheung VG
    Genome Res; 2014 Jan; 24(1):52-63. PubMed ID: 24285722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.
    Lopez C; Schleussner N; Bernhart SH; Kleinheinz K; Sungalee S; Sczakiel HL; Kretzmer H; Toprak UH; Glaser S; Wagener R; Ammerpohl O; Bens S; Giefing M; Sanchez JCG; Apic G; Hubschmann D; Janz M; Kreuz M; Mottok A; Muller JM; Seufert J; Hoffmann S; Korbel JO; Russell RB; Schule R; Trumper L; Klapper W; Radlwimmer B; Lichter P; Kuppers R; Schlesner M; Mathas S; Siebert R
    Haematologica; 2023 Feb; 108(2):543-554. PubMed ID: 35522148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder.
    Kato H; Kushima I; Mori D; Yoshimi A; Aleksic B; Nawa Y; Toyama M; Furuta S; Yu Y; Ishizuka K; Kimura H; Arioka Y; Tsujimura K; Morikawa M; Okada T; Inada T; Nakatochi M; Shinjo K; Kondo Y; Kaibuchi K; Funabiki Y; Kimura R; Suzuki T; Yamakawa K; Ikeda M; Iwata N; Takahashi T; Suzuki M; Okahisa Y; Takaki M; Egawa J; Someya T; Ozaki N
    Transl Psychiatry; 2020 Dec; 10(1):421. PubMed ID: 33279929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype.
    Katainen R; Donner I; Räisänen M; Berta D; Kuosmanen A; Kaasinen E; Hietala M; Aaltonen LA
    J Med Genet; 2022 Jul; 59(7):644-651. PubMed ID: 34281993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Roles of the Histone Demethylase KDM4C in Renal Development and Acute Kidney Injury.
    Pan HC; Chen YH; Fang WC; Wu VC; Sun CY
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate- and cofactor-independent inhibition of histone demethylase KDM4C.
    Leurs U; Lohse B; Rand KD; Ming S; Riise ES; Cole PA; Kristensen JL; Clausen RP
    ACS Chem Biol; 2014 Sep; 9(9):2131-8. PubMed ID: 25014588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
    Jayavelu AK; Schnöder TM; Perner F; Herzog C; Meiler A; Krishnamoorthy G; Huber N; Mohr J; Edelmann-Stephan B; Austin R; Brandt S; Palandri F; Schröder N; Isermann B; Edlich F; Sinha AU; Ungelenk M; Hübner CA; Zeiser R; Rahmig S; Waskow C; Coldham I; Ernst T; Hochhaus A; Jilg S; Jost PJ; Mullally A; Bullinger L; Mertens PR; Lane SW; Mann M; Heidel FH
    Nature; 2020 Dec; 588(7836):157-163. PubMed ID: 33239784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies.
    Scott LM; Gandhi MK
    Blood Rev; 2015 Nov; 29(6):405-15. PubMed ID: 26123794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.
    Young LC; Hendzel MJ
    Biochem Cell Biol; 2013 Dec; 91(6):369-77. PubMed ID: 24219278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylases.
    Kristensen JB; Nielsen AL; Jørgensen L; Kristensen LH; Helgstrand C; Juknaite L; Kristensen JL; Kastrup JS; Clausen RP; Olsen L; Gajhede M
    FEBS Lett; 2011 Jun; 585(12):1951-6. PubMed ID: 21575637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
    Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
    Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2
    Staehle AM; Peeken JC; Vladimirov G; Hoeness ME; Bojtine Kovacs S; Karantzelis N; Gruender A; Koellerer C; Jutzi JS; Pahl HL; Staehle HF
    Leukemia; 2023 Apr; 37(4):919-923. PubMed ID: 36709354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Demethylases KDM4A and KDM4C Regulate Differentiation of Embryonic Stem Cells to Endothelial Cells.
    Wu L; Wary KK; Revskoy S; Gao X; Tsang K; Komarova YA; Rehman J; Malik AB
    Stem Cell Reports; 2015 Jul; 5(1):10-21. PubMed ID: 26120059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KDM4A/KDM4C/NF-κB and WDR5 epigenetic cascade regulates the activation of B cells.
    Hung KH; Woo YH; Lin IY; Liu CH; Wang LC; Chen HY; Chiang BL; Lin KI
    Nucleic Acids Res; 2018 Jun; 46(11):5547-5560. PubMed ID: 29718303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism.
    Zhao E; Ding J; Xia Y; Liu M; Ye B; Choi JH; Yan C; Dong Z; Huang S; Zha Y; Yang L; Cui H; Ding HF
    Cell Rep; 2016 Jan; 14(3):506-519. PubMed ID: 26774480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into The Function and Regulation of Jumonji C Lysine Demethylases as Hypoxic Responsive Enzymes.
    Chopra A; Adhikary H; Willmore WG; Biggar KK
    Curr Protein Pept Sci; 2020; 21(7):642-654. PubMed ID: 31889485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.